011

management. Only a few reports have included outcomes
of CEA in patients with stroke in evolution. In general the
stroke/death rates range from 9.2% to 26.2%.230,248,250-252
This reflects the heterogenous group of patients and lack of
standard selection criterion for intervention. There are no
data on unoperated-on controls for comparison. The lack
of high-quality